Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
InterStim™ systems have been implanted in over 325,000 patients*, and evaluated in more than 1,000 published clinical articles, including long-term (5-year) data for urinary incontinence, retention, and faecal incontinence.1-3
Use these convenient online courses to build your knowledge of InterStim™ Therapy.
See coursesReengineered lead designed with you and the patient in mind. Understand the two testing options available so more patients can say yes to the test.
Learn about evaluationsSiegel, S., Noblett, K.,Mangel J, et al. " Five Year Follow-up Results of a Prospective, Multicenter Study in Overactive Bladder Subjects Treated with Sacral Neuromodulation." J Urol.2018;199(1), 229 – 236.
Hull T, Giese C, Wexner SD, et al. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013;56(2):234-245.
van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol. 2007 Nov;178(5):2029-34.
Under certain conditions; see approved labeling for details. Patients with InterStim™ SureScan™ MRI leads only.